Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
NCT07545395
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A or B
Interventions
DRUG:
KN057
Sponsor
Suzhou Alphamab Co., Ltd.